Chloride channel disorders (Q94763): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/1972433873 / rank | |||
Normal rank | |||
Revision as of 10:10, 16 August 2026
Mutations in chloride channels (CLCN1) cause myotonia congenita, a non-dystrophic muscle diseases. Both autosomal dominant (Thomsen disease) and recessive (Becker disease) types have been described. Myotonia usually begins in the first or second decade of life, with men more severely affected than women. Patients classically have a hypertrophic, muscular build and experience a characteristic improvement in myotonia with exercise (“warm-up”). Virtually all patients report stiffness, with muscle pain and fatigue affecting quality of life
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1972433873 |
||
| English | Chloride channel disorders |
Mutations in chloride channels (CLCN1) cause myotonia congenita, a non-dystrophic muscle diseases. Both autosomal dominant (Thomsen disease) and recessive (Becker disease) types have been described. Myotonia usually begins in the first or second decade of life, with men more severely affected than women. Patients classically have a hypertrophic, muscular build and experience a characteristic improvement in myotonia with exercise (“warm-up”). Virtually all patients report stiffness, with muscle pain and fatigue affecting quality of life |
